You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

standard uptake value (SUV)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Semi-automated Segmentation Methods of SSTR PET for Dosimetry

Not yet recruiting
  • Refractory Meningioma
  • To evaluate the SUVmean (Standard Uptake Value) as a predictive factor of the tumor absorbed dose compared to the SUVmax
  • (no location specified)
Sep 8, 2022

Breast Cancer Trial in United States (Positron emission tomography (PET), Trastuzumab, Pertuzumab)

Active, not recruiting
Has Results
  • Breast Cancer
  • Positron emission tomography (PET)
  • +2 more
  • Birmingham, Alabama
  • +9 more
Jan 20, 2023

Pheochromocytoma, Paraganglioma Trial in Philadelphia ([18F]FluorThanatrace ([18F]FTT))

Not yet recruiting
  • Pheochromocytoma
  • Paraganglioma
  • [18F]FluorThanatrace ([18F]FTT)
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Dec 1, 2022

Alzheimer's Disease, Mild Cognitive Impairment Due to Alzheimer's Disease, Healthy Volunteers Trial in Wuhan ([18F]APN-1607)

Recruiting
  • Alzheimer's Disease
  • +2 more
  • Wuhan, Hubei, China
    Union Hospital Tongji Medical College Huazhong University of Sci
Sep 13, 2022

Arterial Stiffness Trial in Vandoeuvre les Nancy cedex (Measure of aortic inflammation)

Completed
  • Arterial Stiffness
  • Measure of aortic inflammation
  • Vandoeuvre les Nancy cedex, France
    CHRU Nancy
Nov 28, 2023

Prostate Cancer, PET/CT Trial in Hefei ([68Ga]Ga-PSMA-D5, [68Ga]Ga-PSMA-11)

Recruiting
  • Prostate Cancer
  • PET/CT
  • Hefei, Anhui, China
    The First Affiliated Hospital of China University of Science and
Jul 19, 2023

Insulinoma Trial in Fuzhou (68Ga-NOTA-exendin-4)

Recruiting
  • Insulinoma
  • Fuzhou, Fujian, China
    Department of Nuclear Medicine, First Affiliated Hospital of Fuj
Jul 29, 2022

Myocardial Fibrosis Trial in Nanjing (68Ga/18F-FAPI-04)

Recruiting
  • Myocardial Fibrosis
  • Nanjing, Jiangsu, China
    Nanjing First Hospital
May 11, 2023

Pancreatic Adenocarcinoma Trial in Dallas (drug, procedure, other)

Completed
Has Results
  • Pancreatic Adenocarcinoma
  • 3'-deoxy-3'-[F-18] fluorothymidine: [F-18]FLT
  • +3 more
  • Dallas, Texas
    UT Southwestern Medical Center
Oct 10, 2022

Metastatic Malignant Solid Tumor Trial in Duarte (drug, procedure, radiation)

Not yet recruiting
  • Metastatic Malignant Solid Neoplasm
  • Copper Cu 64-DOTA-pembrolizumab
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Feb 13, 2023

Coronary Artery Disease Trial in Basel (99mTc-sestamibi myocardial perfusion SPECT, 82Rb-Chloride myocardial perfusion PET with

Recruiting
  • Coronary Artery Disease
  • 99mTc-sestamibi myocardial perfusion SPECT
  • 82Rb-Chloride myocardial perfusion PET with CCTA
  • Basel, Switzerland
    Clinic of Radiology & Nuclear Medicine, University Hospital of B
Dec 7, 2021

Prostate Cancer Trial (Pylarify Piflufolastat Flourine-18 (18F-DCFPyL))

Not yet recruiting
  • Prostate Cancer
  • Pylarify Piflufolastat Flourine-18 (18F-DCFPyL)
  • (no location specified)
Jan 26, 2023

Hematopoietic and Lymphoid System Tumor, Malignant Solid Tumor Trial in Duarte (procedure, other, device)

Recruiting
  • Hematopoietic and Lymphoid System Neoplasm
  • Malignant Solid Neoplasm
  • Computed Tomography
  • +3 more
  • Duarte, California
    City of Hope Medical Center
May 3, 2023

Non-Hodgkin Lymphoma, Multiple Myeloma Trial in New York ([68Ga]-Pentixafor)

Recruiting
  • Non-Hodgkin Lymphoma
  • Multiple Myeloma
  • New York, New York
    Memorial Sloan Kettering Cancer Center
May 4, 2022

Lung Inflammation Trial in Saint Louis (64Cu-DOTA-ECL1i)

Recruiting
  • Lung Inflammation
  • Saint Louis, Missouri
    Washington University School of Medicine
Oct 3, 2022

Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Malignant Tumor in the Spine Trial in Houston (Computed Tomography,

Recruiting
  • Metastatic Head and Neck Squamous Cell Carcinoma
  • Metastatic Malignant Neoplasm in the Spine
  • Computed Tomography
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 13, 2022

Tumour Trial in Hangzhou (Mirabegron)

Recruiting
  • Tumour
  • Hangzhou, Zhejiang, China
    Zhejiang Provincial People's Hospital
Mar 9, 2023

Hypermetabolism Due to Defect in Mitochondria, Luft Disease Trial in Toronto (18F FDG PET/CT)

Completed
  • Hypermetabolism Due to Defect in Mitochondria
  • Luft Disease
  • 18F FDG PET/CT
  • Toronto, Canada
    The Hospital for Sick Children
Dec 21, 2022

Metastatic Breast Carcinoma, Locally Advanced Breast Cancer, Cancer of Pancreas Trial in Brussels (68GaNOTA-Anti-HER2 VHH1)

Recruiting
  • Metastatic Breast Carcinoma
  • +13 more
  • 68GaNOTA-Anti-HER2 VHH1
  • Brussels, Brussel, Belgium
    Uz Brussel
Dec 17, 2021

Positron-Emission Tomography, Metastatic Solid Tumors Trial in United States (8?Zr-Df-IAB22M2C)

Completed
  • Positron-Emission Tomography
  • Metastatic Solid Tumors
  • Birmingham, Alabama
  • +14 more
Nov 15, 2022

Endometrial Cancer, Ovarian Cancer Trial in Sherbrooke (Loperamide Pill, hyoscine-n-butylbromide)

Recruiting
  • Endometrial Cancer
  • Ovarian Cancer
  • Sherbrooke, Quebec, Canada
    Centre de recherche du CHUS
Oct 31, 2022

Breast Cancer, Brain Metastases Trial in New York (Brain Imaging with 18F-FES)

Not yet recruiting
  • Breast Cancer
  • Brain Metastases
  • Brain Imaging with 18F-FES
  • New York, New York
    New York-Presbyterian/Weill Cornell Medical Center
Oct 2, 2023

Cervical Cancer, Endometrial Cancer Trial in United States (18F-Fluorodeoxyglucose (18F-FDG), PET/CT imaging, PET/MRI imaging)

Active, not recruiting
  • Cervical Cancer
  • Endometrial Cancer
  • 18F-Fluorodeoxyglucose (18F-FDG)
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
Jan 3, 2023

FUR to Quantify Tumor Glucose Consumption in Oncologic PET

Not yet recruiting
  • Lung Cancer
  • Lymphoma
  • FDG PET/CT
  • Maastricht, Limburg, Netherlands
    Academisch ziekenhuis Maastricht
Jan 31, 2023

Neuroendocrine Tumors, Meningioma, Neuroblastoma Trial in Iowa City (radiation, diagnostic test, drug)

Active, not recruiting
  • Neuroendocrine Tumors
  • +3 more
  • 90Y-DOTA tyr3-Octreotide
  • +2 more
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
Oct 6, 2022